𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Liver transplantation for fulminant hepatitis related to nevirapine therapy

✍ Scribed by Sophie Buyse; Eric Vibert; Mylène Sebagh; Teresa Antonini; Philippe Ichai; Denis Castaing; Didier Samuel; Jean-Charles Duclos-Vallée


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
270 KB
Volume
12
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

✦ Synopsis


Drug-induced hepatotoxicity is an important cause of hepatocellular injury. Non-nucleoside retroviral transcriptase inhibitors are known to cause hepatotoxicity. We describe a detailed case of fulminant hepatitis induced by nevirapine (Viramune) and treated by liver transplantation.


📜 SIMILAR VOLUMES


Liver transplantation for fulminant hepa
✍ Wall, William J. ;Adams, Paul C. 📂 Article 📅 1995 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 462 KB

s an indication for transplantation, fulminant A hepatic failure (FHF) accounts for approximately 7% of the liver transplantations currently performed in the United States and This percentage is very small in comparison with the number of transplants performed for chronic liver disease, but FHF domi

Antituberculous therapy–induced fulminan
✍ Ramazan Idilman; Sadik Ersoz; Sahin Coban; Ozlem Kumbasar; Hakan Bozkaya 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

Standard antituberculous therapy including isoniazid, rifampin, ethambutol, and pyrazinamide is widely used for the treatment of active tuberculosis. Its most important side effect is hepatotoxicity, ranging from asymptomatic transaminitis to fulminant hepatic failure. A 19-year-old woman was admitt

Liver transplantation for hepatitis C vi
✍ Nancy L. Ascher; John R. Lake; Jean Emond; John Roberts 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB 👁 1 views

Since the introduction of techniques to reliably identify antibody to the hepatitis C virus and quantitation of hepatitis C virus, there has been an increasing interest in the behavior of chronic hepatitis C infection with liver transplantation. Ninety-seven patients with chronic active hepatitis C